Image

A Prospective Cohort Study of Clinical and Process Outcomes of Older Adults That Transition Through the Geriatric Emergency Medicine Unit(GEM-U)

A Prospective Cohort Study of Clinical and Process Outcomes of Older Adults That Transition Through the Geriatric Emergency Medicine Unit(GEM-U)

Recruiting
75 years and older
All
Phase N/A

Powered by AI

Overview

This study will characterise the patients using the Geriatric Emergency Medicine Unit, a unit which provides specialist care for patients aged 75 years and older attending the emergency department. It will examine how this specialist care impacts their health in terms of a number of different outcomes, such as; function, quality of life and health care usage; for example admission to the acute hospital.

Description

The emergency department is a particularly challenging and busy environment, particularly for older adults living with frailty. It is widely acknowledged throughout the literature and national healthcare strategy that these older adults require holistic, person centred care that targets the intricacies of multifaceted, complex health issues.

The geriatric emergency medicine unit (GEM-U) aims to provide such care through the framework of comprehensive geriatric assessment, with in-put from a team of healthcare disciplines. The main aim of this study is to look at how this specialist care impacts patient outcomes, such as acute admission. Clinical and process outcomes of participants will be examined using patient reported outcome measures, which will include;

  1. Global measure of function (Barthel Index)
  2. Delirium screen (4AT +/- Delirium Rating Scale)\*
  3. Frailty status (Clinical Frailty Scale)
  4. Nutritional status (Mini Nutritional Assesment)
  5. Quality of life (EuroQoL-5D-5L).
  6. Patient satisfaction (PSQ-18).

Participants will be followed at 30 days and 6 months post recruitment. All participants will give fully informed consent. The STrengthening the Reporting of OBservational studies in Epidemiology (STROBE) standardised reporting guidelines will be followed in the conduct and reporting of this research. Data will be statistically analysed

Eligibility

Inclusion Criteria:

  • Older adults aged ≥75 years
  • Manchester Triage System category 2-5
  • Screen positive for risk of adverse outcomes after ED visit (≥ 2 on ISAR screening tool)
  • Presenting with a medical condition
  • Reviewed by the Older Persons Integrated Care Team

Exclusion Criteria:

  • Patients presenting with a non-medical issue including major trauma or hip fracture
    • Patients presenting with acute stroke or transient ischaemic attack
    • Patients more appropriate to another alternative pathway e.g. deep vein thrombosis pathway, low risk chest pain pathway
    • Patients with acute coronary syndrome or unstable arrthymia
    • Patients requiring care in the resuscitation room
    • Patients with head injury (unless appropriate assessment and management has been fully completed by ED team)
    • Patients with possible spinal injury (unless appropriate assessment and management has been fully completed by ED/orthopaedic team)
    • Patients with low Glasgow Coma Scale
    • Other exclusions at the discretion of the Older Persons Integrated Care team depending on team capacity and expertise
    • Exclusion criteria as set out above, are in line with those set out in the UHL Operating Policy of the Older Persons Integrated Care Team.

Study details
    Frailty

NCT07237334

University of Limerick

1 February 2026

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.